These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19169980)

  • 1. [Do angiotensin receptor blockers increased the risk of myocardial infarction? The landscape after ONTARGET study].
    Grajek S
    Kardiol Pol; 2008 Dec; 66(12):1313-24. PubMed ID: 19169980
    [No Abstract]   [Full Text] [Related]  

  • 2. ARBs and Myocardial Infarction.
    Med Lett Drugs Ther; 2005 May; 47(1208):38-9. PubMed ID: 15880086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin receptor blockers and myocardial infarction.
    Verma S; Strauss M
    BMJ; 2004 Nov; 329(7477):1248-9. PubMed ID: 15564232
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin receptor blockers and myocardial infarction: analysis of evidence is incomplete and inaccurate.
    McMurray J
    BMJ; 2005 May; 330(7502):1269; author reply 1270-1. PubMed ID: 15920134
    [No Abstract]   [Full Text] [Related]  

  • 5. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin receptor blockers and secondary stroke prevention: the MOSES study.
    Dowlatshahi D; Hill MD
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):459-64. PubMed ID: 19419253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials.
    Volpe M; Tocci G; Sciarretta S; Verdecchia P; Trimarco B; Mancia G
    J Hypertens; 2009 May; 27(5):941-6. PubMed ID: 19381108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II receptor blockers and coronary artery disease: 'presumed innocents'.
    Volpe M; Tocci G; Savoia C
    Eur Heart J; 2006 Jun; 27(12):1506-7; author reply 1508. PubMed ID: 16684781
    [No Abstract]   [Full Text] [Related]  

  • 9. ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses.
    Onuigbo MA
    Arch Intern Med; 2009 Oct; 169(19):1810; author reply 1810-1. PubMed ID: 19858442
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin receptor blockers and risk of myocardial infarction: systematic review.
    McDonald MA; Simpson SH; Ezekowitz JA; Gyenes G; Tsuyuki RT
    BMJ; 2005 Oct; 331(7521):873. PubMed ID: 16183653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin receptor blockers and myocardial infarction: direct comparative studies are needed.
    Opie LH
    BMJ; 2005 May; 330(7502):1270; author reply 1270-1. PubMed ID: 15920136
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox.
    Strauss MH; Hall AS
    Circulation; 2006 Aug; 114(8):838-54. PubMed ID: 16923768
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inhibition of the renin angiotensin system in pregnancy and risk of fetal malformations].
    Lonati C; Morganti A
    Pediatr Med Chir; 2009; 31(3):137-9. PubMed ID: 19739495
    [No Abstract]   [Full Text] [Related]  

  • 14. Questioning the leading role of angiotensin receptor blockers in the management of hypertension.
    Baglioni P; Mascitelli L; Pezzetta F
    Int J Clin Pract; 2007 Aug; 61(8):1420. PubMed ID: 17627721
    [No Abstract]   [Full Text] [Related]  

  • 15. [Angiotensin receptor antagonists. A clinical-pharmacologic overview].
    Bertsche T; Schulz M
    Med Monatsschr Pharm; 2005 Jan; 28(1):4-16; quiz 17-8. PubMed ID: 15693598
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypertension 2007-2008].
    Chatzikyrkou C; Menne J; Haller H
    Med Klin (Munich); 2009 Aug; 104(8):614-21. PubMed ID: 19701732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.
    Fournier A; Oprisiu-Fournier R; Serot JM; Godefroy O; Achard JM; Faure S; Mazouz H; Temmar M; Albu A; Bordet R; Hanon O; Gueyffier F; Wang J; Black S; Sato N
    Expert Rev Neurother; 2009 Sep; 9(9):1413-31. PubMed ID: 19769454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin receptor blockers do not increase risk of myocardial infarction.
    Tsuyuki RT; McDonald MA
    Circulation; 2006 Aug; 114(8):855-60. PubMed ID: 16923769
    [No Abstract]   [Full Text] [Related]  

  • 19. Now or never: optimal antihypertensive therapy in the elderly.
    Prisant LM
    Prev Cardiol; 2008; 11(4):201-9. PubMed ID: 19476572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II receptor blockers in the treatment of the cardiovascular disease continuum.
    Chrysant SG
    Clin Ther; 2008; 30 Pt 2():2181-90. PubMed ID: 19281913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.